Delivery Order SPE2DB22D3501-SPE2DB24FWP00
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Remifentanil 1 mg vials. The contract has a ceiling value of $1,755.60 and a period of performance through October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,489.05 contract is for the delivery of Remifentanil 5 mg vials, with a period of performance ending on June 30, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a firm fixed price ceiling value of $3,072.30 and a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,633.40 fixed-price contract is for the supply of Remifentanil 2 mg vials, a specialty pharmaceutical product used in military treatment facilities. The contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REMIFENTANIL 1 MG VIALS, with a Ceiling Value of $5,867.68 and a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,734.40 firm fixed-price delivery order is for the supply of 5 milligram vials of the pharmaceutical drug Remifentanil. This contract has an ultimate completion date of September 27, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, with a ceiling value of $8,222.88, is for the delivery of 2 mg vials of the drug remifentanil. It is a firm fixed-price delivery order contract with a period of performance through January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $2,728.16. The contract is for the delivery of REMIFENTANIL 2 MG VIALS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a ceiling value of $4,253.64 and a performance period ending on August 29, 2024. The contract has a firm fixed price pricing structure and does not utilize any set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite...